Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11574404 | Predicting recurrence and overall survival using radiomic features correlated with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC) | Anant Madabhushi, Pranjal Vaidya, Kaustav Bera, Prateek Prasanna | 2023-02-07 |
| 11350901 | Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography | Anant Madabhushi, Pranjal Vaidya, Kaustav Bera | 2022-06-07 |
| 11055844 | Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC) | Anant Madabhushi, Xiangxue Wang, Cristian Barrera | 2021-07-06 |
| 10956795 | Predicting recurrence in early stage non-small cell lung cancer (NSCLC) using spatial arrangement of clusters of tumor infiltrating lymphocytes and cancer nuclei | Anant Madabhushi, Xiangxue Wang | 2021-03-23 |
| 10950351 | Methods and apparatus for predicting benefit from immunotherapy using tumoral and peritumoral radiomic features | Anant Madabhushi, Mahdi Orooji, Niha Beig | 2021-03-16 |
| 10902256 | Predicting response to immunotherapy using computer extracted features relating to spatial arrangement of tumor infiltrating lymphocytes in non-small cell lung cancer | Anant Madabhushi, Xiangxue Wang, Cristian Barrera | 2021-01-26 |
| 10846367 | Predicting recurrence in early stage non-small cell lung cancer (NSCLC) with integrated radiomic and pathomic features | Anant Madabhushi, Xiangxue Wang, Pranjal Vaidya | 2020-11-24 |
| 10839513 | Distinguishing hyperprogression from other response patterns to PD1/PD-L1 inhibitors in non-small cell lung cancer with pre-therapy radiomic features | Pranjal Vaidya, Kaustav Bera, Anant Madabhushi | 2020-11-17 |
| 10575774 | Predicting immunotherapy response in non-small cell lung cancer with serial radiomics | Anant Madabhushi, Yuanqi Xie | 2020-03-03 |
| 10492723 | Predicting immunotherapy response in non-small cell lung cancer patients with quantitative vessel tortuosity | Anant Madabhushi, Mehdi Alilou | 2019-12-03 |
| 10458895 | Predicting response to pemetrexed chemotherapy in non-small cell lung cancer (NSCLC) with baseline computed tomography (CT) shape and texture features | Anant Madabhushi, Mahdi Orooji, Sagar Rakshit, Mehdi Alilou, Niha Beig | 2019-10-29 |
| 10441215 | Predicting immunotherapy response in non-small cell lung cancer with serial quantitative vessel tortuosity | Anant Madabhushi, Yuanqi Xie | 2019-10-15 |
| 10441225 | Predicting disease recurrence following trimodality therapy in non-small cell lung cancer using computed tomography derived radiomic features and clinico-pathologic features | Anant Madabhushi, Mohammadhadi Khorrami | 2019-10-15 |
| 10346975 | Computerized analysis of computed tomography (CT) imagery to quantify tumor infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) | Anant Madabhushi, Mahdi Orooji, Sagar Rakshit, Mehdi Alilou, Niha Beig | 2019-07-09 |
| 10078895 | Prediction of recurrence of non-small cell lung cancer with tumor infiltrating lymphocyte (TIL) graphs | Anant Madabhushi, Xiangxue Wang, German Corredor Prada | 2018-09-18 |
| 10049770 | Prediction of recurrence of non-small cell lung cancer | Anant Madabhushi, Xiangxue Wang | 2018-08-14 |